Evidence map›Paper›PMID 41209080›Full record

ArticleInternational journal of pharmaceutics: X2025

Targeted probiotic tabletting: A hybrid active learning and finite element modelling approach for process optimisation.

Bide Wang, Xilu Wang, Oleksiy V Klymenko, Jiawei Hu, Rachael Gibson, Andrew Middleton, Chuan-Yu Wu

Abstract read
In one paragraph

Article in International journal of pharmaceutics: X, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Bide WangSchool of Chemistry and Chemical Engineering, University of Surrey, Guildford GU2 7XH, UK.
Xilu WangSchool of Computer Science and Electronic Engineering, University of Surrey, Guildford GU2 7XH, UK.
Oleksiy V KlymenkoSchool of Chemistry and Chemical Engineering, University of Surrey, Guildford GU2 7XH, UK.
Jiawei HuSchool of Chemistry and Chemical Engineering, University of Surrey, Guildford GU2 7XH, UK.
Rachael GibsonP&G Innovation Centre, Reading, Berkshire RG2 0QE, UK.
Andrew MiddletonP&G Innovation Centre, Reading, Berkshire RG2 0QE, UK.
Chuan-Yu WuSchool of Chemistry and Chemical Engineering, University of Surrey, Guildford GU2 7XH, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tablets are an efficient dosage form for delivering probiotics. Prior studies have identified compression pressure, compression speed, and precompression pressure as critical process parameters determining probiotic survival during tabletting. However, due to the labour-intensive and time-consuming nature of experimental investigations, most previous studies focused on evaluating the impact of individual parameters in isolation. Consequently, the rapid and systematic identification of optimal process parameters to maximise probiotic survival remains a significant and unresolved challenge in pharmaceutical formulation research. To address this gap, an integrated approach combining active learning (AL) based Gaussian process regression (GPR) with finite element (FE) modelling was developed to systematically explore the compaction parameter space and identify optimal process conditions. All data utilised in AL were generated using an FE model that was specifically developed to predict viability of probiotics during tabletting. Remarkably, the integrated approach achieved high prediction performance after only 78 iterations, demonstrating a coefficient of determination (R

Indexed as

Active learningFinite element methodGaussian process regressionProbioticTabletting

Identifiers

PMID41209080
PMCPMC12590431

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.